will the fda ban compounded tirzepatide versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said FDA moves to remove GLP-1
Description
Zepbound may face restrictions or higher out-of-pocket costs when prescribed for weight loss
Its important to know that compounded GLP-1 medications arent FDA-approved, and the FDA hasnt reviewed them for safety, quality, or how well they work
No differences were observed when comparing tirzepatide with semaglutide, except for tirzepatide 15 mg vs semaglutide 0.5 mg (ESM Table 17)
Isoniazid (for tuberculosis) may reduce vitamin B6 levels and raise nerve-damage risk
Always double-check your unit markings against your providers instructions
